Ireland· IE-PA-PA1591/003/001
Amsalyo 75 mg powder for concentration for solution infusion
A amsacrine product containing amsacrine, registered in Ireland by Eurocept International BV. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Amsacrine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XX01 (amsacrine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Amsacrine · ATC L01XX01
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Amsacrine
- Manufacturer
- Eurocept International BV
- Country
- Ireland (IE)
- ATC code
- L01XX01
- ATC class
- Amsacrine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1591/003/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAmlyoEurocept
- FinlandAmsalyoEurocept International BV
- IcelandAmsalyoEurocept International B.V.
- SwedenAmsalyo 75 mg Pulver till koncentrat till infusionsvätska, lösningEurocept International B.V.
- United KingdomAmsidine 75mg/1.5ml concentrate and solvent for solution for infusion vialsEurocept International bv
- GermanyAmlyoEurocept International Bv
- NetherlandsAmsalyo 75 mg poeder voor concentraat voor oplossing voor infusieEurocept International B.V.
- BelgiumAmsidine 75 mg/1.5 mlEurocept International
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Amlyo
- Germany · Amlyo, Amsidyl
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Norway · Amsalyo
- Sweden · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17531af8-b30b-414b-8ed2-84164a9e3f8a GET /v1/drugs/17531af8-b30b-414b-8ed2-84164a9e3f8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L01XX01"
],
"strength": null,
"pa_number": "PA1591/003/001",
"substances": [
"Amsacrine"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "26/01/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about amsacrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.